TCF3 protein was initially reported to play particularly important roles during lymphocyte development [22], and it is dysregulated in various cancers including lymphoma, pancreatic cancer, breast cancer, colorectal cancer, and prostate cancer [23–27]. This evidence concerns the gene TCF3 and lymphoma.